RARE vs HBI

Comparison between Ultragenyx Pharmaceutical Inc (RARE, Company) and Hanesbrands, Inc. (HBI, Company).

RARE is from the Healthcare sector, while HBI is from the Consumer Cyclical sector.

5-Year PerformanceHBI has outperformed RARE, delivering a return of -18.5% compared to -25.0%

RARE vs HBI - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RARE(COMPANY)	HBI(COMPANY)
Market Cap	$2.30B	$2.29B
Max Drawdown	89.57%	89.68%
Sharpe Ratio	-0.37	0.34
5Y Beta	1.01	1.15
Industry	Biotechnology	Apparel Manufacturing
P/E Ratio	-3.73	6.94
Forward P/E	N/A	9.14
PEG Ratio	-0.62	0.19
5Y Dividends CAGR	N/A	0.00%
5Y EPS CAGR	15.22%	-5.42%
Debt to Equity	0.00%	524.58%
Free Cash Flow Yield	-21.84%	-0.36%
P/S Ratio	3.44	0.65
P/B Ratio	247.70	5.13

Market Cap

Winner

RARE

$2.30B

HBI

$2.29B

Max Drawdown

Winner

RARE

89.57%

HBI

89.68%

Sharpe Ratio

RARE

-0.37

Winner

HBI

0.34

5Y Beta

Winner

RARE

1.01

HBI

1.15

Industry

RARE

Biotechnology

HBI

Apparel Manufacturing

P/E Ratio

Winner

RARE

-3.73

HBI

6.94

Forward P/E

RARE

N/A

HBI

9.14

PEG Ratio

Winner

RARE

-0.62

HBI

0.19

5Y Dividends CAGR

RARE

N/A

HBI

0.00%

5Y EPS CAGR

Winner

RARE

15.22%

HBI

-5.42%

Debt to Equity

Winner

RARE

0.00%

HBI

524.58%

Free Cash Flow Yield

RARE

-21.84%

Winner

HBI

-0.36%

P/S Ratio

RARE

3.44

Winner

HBI

0.65

P/B Ratio

RARE

247.70

Winner

HBI

5.13

RARE vs HBI - Historical Returns

Returns include dividend reinvestment.

Period	RARE	HBI
1 month	-12.40%	+0.00%
3 months	+2.10%	+0.00%
6 months	-39.77%	+0.00%
1 year	-40.64%	+33.40%
5 years(CAGR)	-24.97%	-18.45%
10 years(CAGR)	-11.34%	-11.25%
Max(CAGR)	-5.18%	+3.00%

RARE

-12.40%

Winner

HBI

+0.00%

Winner

RARE

+2.10%

HBI

+0.00%

RARE

-39.77%

Winner

HBI

+0.00%

RARE

-40.64%

Winner

HBI

+33.40%

5Y(CAGR)

RARE

-24.97%

Winner

HBI

-18.45%

10Y(CAGR)

RARE

-11.34%

Winner

HBI

-11.25%

Max(CAGR)

RARE

-5.18%

Winner

HBI

+3.00%

RARE vs HBI - Annual Returns (2006 - 2026)

Returns include dividend reinvestment.

Year	RARE	HBI
2026	-7.16%	+0.00%
2025	-44.11%	-19.43%
2024	-12.66%	+82.10%
2023	+5.05%	-33.73%
2022	-45.11%	-60.10%
2021	-38.38%	+19.49%
2020	+221.11%	+4.94%
2019	+2.37%	+21.61%
2018	-11.79%	-39.17%
2017	-33.71%	-2.77%
2016	-30.97%	-25.07%
2015	+141.77%	+17.86%
2014	+3.86%	+62.68%
2013	N/A	+99.44%
2012	N/A	+61.42%
2011	N/A	-14.64%
2010	N/A	+2.83%
2009	N/A	+82.93%
2008	N/A	-51.85%
2007	N/A	+13.02%
2006	N/A	+11.89%

RARE vs HBI Drawdown Comparison

The maximum drawdown for RARE was -89.57%, occurring on Mar 24, 2026. This drawdown has not yet recovered.

The maximum drawdown for HBI was -86.55%, occurring on Sep 27, 2023. This drawdown has not yet recovered.

The current RARE drawdown is -87.65%. The current HBI drawdown is -75.62%.

Rank	RARE	HBI
#1	-89.57% Dec 23, 2020 - Mar 24, 2026	-86.55% Apr 23, 2015 - Sep 27, 2023
#2	-74.79% Jul 20, 2015 - Dec 8, 2020	-84.59% May 15, 2008 - Jan 15, 2013
#3	-49.59% Mar 12, 2014 - Apr 22, 2015	-33.65% Jul 30, 2007 - Apr 16, 2008
#4	-18.98% Apr 24, 2015 - May 12, 2015	-13.64% Mar 29, 2007 - Jul 26, 2007
#5	-14.60% Jan 31, 2014 - Feb 12, 2014	-9.56% Dec 5, 2013 - Jan 30, 2014
#6	-8.63% Feb 21, 2014 - Mar 10, 2014	-9.49% Oct 27, 2006 - Nov 22, 2006
#7	-6.40% Dec 8, 2020 - Dec 11, 2020	-9.00% Sep 19, 2013 - Oct 31, 2013
#8	-5.97% Jun 2, 2015 - Jun 17, 2015	-8.28% Nov 28, 2014 - Jan 29, 2015
#9	-5.14% Jul 7, 2015 - Jul 9, 2015	-8.14% Oct 6, 2014 - Nov 19, 2014
#10	-5.08% Jun 23, 2015 - Jul 1, 2015	-7.32% Aug 1, 2013 - Sep 19, 2013
#11	-2.70% Feb 12, 2014 - Feb 20, 2014	-7.12% Dec 1, 2006 - Jan 8, 2007
#12	-2.65% May 21, 2015 - May 27, 2015	-7.04% Aug 1, 2014 - Sep 3, 2014
#13	-1.60% May 28, 2015 - Jun 2, 2015	-7.00% Apr 1, 2014 - Apr 25, 2014
#14	-1.50% Jul 14, 2015 - Jul 17, 2015	-6.42% Apr 10, 2013 - Apr 25, 2013
#15	-1.12% Jul 1, 2015 - Jul 7, 2015	-6.04% Jan 30, 2014 - Feb 13, 2014